triazoles has been researched along with Glomerulonephritis, Membranous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, M; Bubb, M; Chaichian, Y; Chatham, W; Derebail, V; Genovese, M; Gurtovaya, O; Hajian, H; Lim, S; Patel, U; Rao, P; Tumlin, J | 1 |
| Horie, M; Mase, T; Nagaoka, H; Sakurai, Y; Tomioka, K; Yamada, T | 1 |
1 trial(s) available for triazoles and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy.
Topics: Glomerulonephritis, Membranous; Humans; Lupus Erythematosus, Systemic; Pyridines; Triazoles | 2020 |
1 other study(ies) available for triazoles and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.
Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Male; Metabolic Clearance Rate; Methylprednisolone; Piperazines; Platelet Activating Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Ticlopidine; Triazoles | 1991 |